“…The U.S. Preventive Services Task Force recommends against routine screening for CAS in the absence of symptoms. 58 However, this recommendation is based on historical data that do not account for the advances in interventional therapies of CAS, and it does not address high-risk populations, such as those with concomitant coronary disease or those undergoing major cardiovascular procedures. Selective screening of these high-risk populations is indeed an area of ongoing debate.…”